Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study

EVIDENS is an ongoing, prospective, non-interventional study evaluating the effectiveness and safety of nivolumab in lung cancer patients in France (ClinicalTrials.gov NCT03382496). Adults with a pathologically confirmed diagnosis of lung cancer and initiating treatment with nivolumab were recruited...

Descripción completa

Detalles Bibliográficos
Autores principales: Barlesi, Fabrice, Dixmier, Adrien, Debieuvre, Didier, Raspaud, Christophe, Auliac, Jean-Bernard, Benoit, Nicolas, Bombaron, Pierre, Moro-Sibilot, Denis, Audigier-Valette, Clarisse, Asselain, Bernard, Egenod, Thomas, Rabeau, Audrey, Fayette, Jérôme, Sanchez, Myriam Locatelli, Labourey, Jean-Luc, Westeel, Virginie, Lamoureux, Pauline, Cotte, François-Emery, Allan, Victoria, Daumont, Melinda, Dumanoir, Juliette, Reynaud, Dorothée, Calvet, Christophe Yannick, Ozan, Nicolas, Pérol, Maurice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Back Matter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790497/
https://www.ncbi.nlm.nih.gov/pubmed/33457089
http://dx.doi.org/10.1080/2162402X.2020.1744898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790497/
https://www.ncbi.nlm.nih.gov/pubmed/33457089
http://dx.doi.org/10.1080/2162402X.2020.1744898

Ejemplares similares